Clinical Study | Office of Clinical Research

A Phase Ib/II Clinical Study Of Bbi608 (Napabucasin) In Combination With Sorafenib Or Bbi503 (Amcasertib) In Combination With Sorafenib In Adult Patie

Posted Date: May 15, 2019

Boston Biomedical BBI608-503-103HCC

To Be Eligible To Participate In This Study, Patients Must Have Advanced Liver Cancer (Hepatocellula

Bbi608-503-103Hcc, Cancer, Gastrointestinal, Liver, Phase Ib/Ii

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List